Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

Min, Sang-Won, Chen, Xu, Tracy, Tara E, Li, Yaqiao, Zhou, Yungui, Wang, Chao, Shirakawa, Kotaro, Minami, S Sakura +14 more·2015·Nature Medicine
DOI 10.1038/nm.3951

Cited by (518)

Items 401–500 of 518

  1. Artificial Intelligence to Guide Repurposing of Drugs
    Zhimin Fu, Yuxin Yang, Mina K. Chung, Feixiong Cheng · 2026 · Annual Review of Medicine
  2. Pathophysiology of Alzheimer’s Disease: Focus on H3 Receptor Modulators and Their Implications
    Nagaraju Bandaru, Sarad Pawar Naik Bukke, Veera Mani Deepika Pedapati, Gurugubelli Sowjanaya, Vangmai Swaroopa Suggu, Swathi Nalla, Prashik Bhimrao Dudhe, Joseph Obiezu Chukwujekwu Ezeonwumelu, Abdullateef Isiaka Alagbonsi, Hope Onohuean · 2025 · Drugs and Drug Candidates
  3. Neuroimmune Dysfunction in Alzheimer’s Disease and Other Forms of Dementia
    Takuya Yamane, Takeshi Yoshioka, Yusuke Shimo · 2024 · Chemical and Pharmaceutical Bulletin
  4. A New Therapeutic Strategy Targeting Protein Deacetylation for Spinal Cord Injury
    Xinwei Liu, Bin Ma, Haocong Zhang, Ruonan Chai, Liangbi Xiang · 2020 · Neuroscience
  5. Tauopathy
    Hao Chi, Tzu‐Kang Sang, Hui-Yun Chang · 2019 · IntechOpen eBooks
  6. Minimotifs dysfunction is pervasive in neurodegenerative disorders
    Surbhi Sharma, Richard J. Young, Jingchun Chen, Xiangning Chen, Edwin C. T. Oh, Martin R. Schiller · 2018 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  7. Conformational dynamics of Tau in the cell quantified by an intramolecular FRET biosensor in physiological and pathological context
    Cristina Di Primio, Valentina Quercioli, Giacomo Siano, Branislav Kováčech, M Novák, Antonino Cattaneo · 2016 · bioRxiv (Cold Spring Harbor Laboratory)
  8. Decoding stress granules dynamics: Implications for neurodegenerative disease
    Zixuan Wang, Chenyi Yang, Xinyi Wang, Xing Liu, Huan Liu, Xing Liu, Huan Liu, Lin Zhang, Huai Shen, Lin Zhang et al. · 2025 · Progress in Neurobiology
  9. Biomolecular phase separation of microtubule-associated protein tau and its role in the genesis of brain disorders
    Aurgha Kamal Bhandari, Aman Singh Dhami, Rishi Thanavanthan Hemanthlumar, Nishant Mishra, Beula Joslyn, Sindhujit Roy, Jaisri Srinivasan, Kailash Prasad Prajapati, Karunakar Kar, Bibin Gnanadhason Anand · 2025 · Ageing Research Reviews
  10. Clinical Trial Development in Frontotemporal Lobar Degeneration
    Peter Alexander Ljubenkov, Adam L. Boxer · 2022 · Cambridge University Press eBooks
  11. Real-Time Tracking of Vesicles in Living Cells Reveals That Tau-Hyperphosphorylation Suppresses Unidirectional Transport by Motor Proteins
    Eunsang Lee, Dong Hee Kim, Yo Han Song, Kyujin Shin, Sanggeun Song, Minho Lee, Yeongchang Goh, Mi Hee Lim, Ji-Hyun Kim, Jaeyoung Sung et al. · 2024 · Chemical & Biomedical Imaging
  12. Regulation of presynaptic homeostatic plasticity by glial signalling in Alzheimer's disease
    Yimei Cai, Tingting Wang · 2024 · The Journal of Physiology
  13. The advances in acetylation modification in senescence and aging-related diseases
    Maiqi Xu, Wenbin Wang, Saien Lu, Mengyao Xiong, Tong Zhao, Yao Yu, Chunyu Song, Jinjing Yang, Naijin Zhang, Liu Cao et al. · 2025 · Frontiers in Physiology
  14. Untersuchung der epigenetischen Funktionen von Lysin‐Acetyltransferasen mit Methoden der chemischen Biologie
    Maomao He, Zhen Hai Han, Liang Liu, Yujun George Zheng · 2017 · Angewandte Chemie
  15. A Mechanism for the Inhibition of Tau Neurotoxicity: Studies with Artificial Membranes, Isolated Mitochondria, and Intact Cells
    Segev Naveh‐Tassa, Shani Ben-Zichri, Shiran Lacham‐Hartman, Ofek Oren, Zeev Slobodnik, Ekaterina Eremenko, Debra Toiber, Raz Jelinek, Niv Papo · 2021 · ACS Chemical Neuroscience
  16. The human islet amyloid polypeptide reduces hippocampal tauopathy and behavioral impairments in P301S mice without inducing neurotoxicity or seeding amyloid aggregation
    Yingying Yang, Yan-Tao Ren, Meng‐Yu Jia, Chen‐Yang Bai, Xiu-Ting Liang, Huiling Gao, Manli Zhong, Tao Wang, Chuang Guo · 2023 · Experimental Neurology
  17. Insights to develop tau‐directed therapeutics to protect the synaptic integrity for tauopathies
    Eunji Cha, Hak Joong Kim, Sang Min Lim · 2023 · Bulletin of the Korean Chemical Society
  18. Tau pathway‐based gene analysis on PET identifies CLU and FYN in a Korean cohort
    Dahyun Yi, Min Soo Byun, Jong‐Ho Park, Jong‐Won Kim, Gijung Jung, Hyejin Ahn, Jun‐Young Lee, Yun‐Sang Lee, Yoon‐Keun Kim, Koung Mi Kang et al. · 2024 · Alzheimer s & Dementia
  19. The flip side of sirtuins: the emerging roles of protein acetyltransferases in aging
    Prabakaran Nagarajan, Mark R. Parthun · 2020 · Aging
  20. Enantiomers of 2-methylglutamate and 2-methylglutamine selectively impact mouse brain metabolism and behavior
    Adam M. Wawro, Chandresh R. Gajera, Steven Andrew Baker, Robert K. Leśniak, Curt R. Fischer, Nay Lui Saw, Mehrdad Shamloo, Thomas Jude Montine · 2021 · Scientific Reports
  21. Immunotherapeutics for AD: A Work in Progress
    Anuja Sharma, Jaspreet Singh Anand, Yatender Kumar · 2021 · CNS & Neurological Disorders - Drug Targets
  22. Neurodegenerative Diseases as Protein Folding Disorders
    Jeremy D. Baker, Jack M. Webster, Lindsey B. Shelton, John Koren, Vladimir Nikolaevich Uversky, Laura J. Blair, Chad A. Dickey · 2018 · Elsevier eBooks
  23. Drosophila wing is a high-throughput and versatile screening tool for Tau-mediated disease mechanisms and drug discovery
    Miguel Ramírez Moreno, Amber S. Cooper, Tianshun Lian, Jie Liu, Seyedehleila Abtahi, Efthimios M. C. Skoulakis, Lovesha Sivanantharajah, Douglas W. Allan, Amritpal K. Mudher · 2026 · Disease Models & Mechanisms
  24. Sex-specific effects of acetylation on tauopathy in aging htau mice
    Usman Sabir, Bovinari Alistair Csubak, Serguei Ilchenko, MOHAMMAD YUNUS KHALIL ANSARI, Nicholas M. Kanaan, Tsung‐Heng Tsai, Dasarathy Srinivasan, Christine M. Dengler-Crish, Takhar Kasumov · 2026 · Scientific Reports
  25. Epigenetic dynamics of cellular senescence: From mechanistic insights to precision senotherapy
    Xiangjun Hu, Weijing Lai, Mengyuan Liu, Bo Wang · 2026 · Chinese Medical Journal
  26. Molecular and environmental drivers of tau post-translational modifications and tau pathology
    Trevor M. Price, Autumn E. Tucker, Kristen E. Funk · 2026 · Ageing Research Reviews
  27. Therapeutic Approaches Targeting Ferroptosis in Cardiomyopathy
    Yanqian Ruan, Ling Zhang, Lina Zhang, Keyang Zhu · 2023 · Cardiovascular Drugs and Therapy
  28. A comprehensive analysis of MAPT-related genetic risk in Alzheimer’s disease
    Shitao Wang, Guoshuai Luo, Xiangqian Ding, Guangxin Sun, Mengen Zhang, Jingjing Dong, Hui Min Xu, Jinghong Lu, Zongyou Li, Bin Ning et al. · 2025 · IBRO Neuroscience Reports
  29. Tau in Health and Neurodegenerative Diseases
    Dandan Chu, Fei Liu · 2021 · IntechOpen eBooks
  30. Frontotemporal lobar degeneration
    Boram Kim, Ashley Viera-Ortiz, Jessica M. Phan, David John Irwin, Edward B. Lee · 2022 · Elsevier eBooks
  31. Molecular Characterization and Clinical Relevance of Lysine Acetylation Regulators in Urological Cancers
    Jian Zhang, Chunning Zhang, Huali Jiang, Hualong Jiang, Yawei Yuan · 2021 · Frontiers in Oncology
  32. A Blood-Based, Metabolite and Demographic Characteristic Markers Panel For The Diagnosis of Alzheimer's Disease
    Li Ping Yang, Qilong Tan, Wenjing Wan, Zhibin Bu, Cheng Xuan, Caiyan Yu, Jiong Wu, Jing Yan · 2023 · Bioanalysis
  33. Quantification of Methylation and Phosphorylation Stoichiometry
    Christopher A. Ayoub, Khadijah I. Moore, Jeff Kuret · 2024 · Methods in molecular biology
  34. Nanoconjugate Improves Cognitive Deficit and Limits the Pathogenic Tau Burden in Okadaic‐Acid‐Induced Alzheimer's Mice
    Qiuju Liang, Shoubo Xiang, Pengzhen Wang, Lian Chen, Hongyi Cao, Tian Cheng, Tingting Jiang, Hua Zuo, Zhen Tian, Sanjib Bhattacharyya · 2025 · Advanced Therapeutics
  35. PRMT3‐Mediated H4R3me2a Promotes Primary Age‐Related Tauopathy by Driving Tau Hyperphosphorylation in Neuron
    Haotian Liu, Xinnan Liu, Fengyuan Tian, Yashuang Chen, Jingying Li, Xue Bing Wang, Wenying Qiu, Xia Wang, Chao Ma, Wei Ge · 2025 · Advanced Science
  36. Unraveling tau’s fold: Structural dynamics in Alzheimer’s pathogenesis
    Sarita Montaño, Nabil Itzi Luna‐Viramontes, Elvis Cuevas, Pedro Pablo Martínez-Cuevas, Mar Pacheco‐Herrero, Liliana León-López, Andrés Duran Armenta, José Luna‐Muñoz · 2025 · Advances in protein chemistry and structural biology
  37. Protein misfolding and neurodegeneration: Mechanisms, implications, and therapeutic strategies
    Asma Shah, Tharini Karthikeyan, Sheema Hashem, Rakesh Kumar, Ajaz Ahmad Bhat, Muzafar Ahmad Macha · 2025 · Advances in protein chemistry and structural biology
  38. Pathological and Functional Brain Amyloids: A New Concept Explaining the Differences
    Alexey P. Galkin, Vladimir A. Mitkevich, Alexander А. Makarov, Anna A. Valina, Evgeniy I. Sysoev · 2025 · International Journal of Molecular Sciences
  39. Tauopathies and its therapeutic interventions in Alzheimer’s disease
    Shweta Kishor Sonawane, Nagaraj Rangappa, Hariharakrishnan Chidambaram, Subashchandrabose Chinnathambi · 2026 · Advances in pharmacology
  40. Simultaneous Profiling and Quantification of Tau and Its Phosphorylated Isomers Using Engineered FraC Nanopores
    Yu Xin, Defu Liu, Ma Yk, Zhijing Zhang, Peng Chen, Mengze Wu, Yue Li, Shanchuan Chen, Shixin Yan, Guiqin Song et al. · 2026 · Nano Letters
  41. Biophysical assessment of the molecular mechanisms of Tau aggregation and its role in Alzheimer's disease
    Joshua T. Skrehot, Dmitry Kurouski · 2026 · Protein Science
  42. Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease ☆
    Gabriel S. Stephens, Jason C. You, Chia-Hsuan Fu, Jeannie Chin · 2017 · Elsevier eBooks
  43. Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models
    Lars Matthias Ittner, Wei S. Lee, Kristie Stefanoska, Prita Riana Asih, Yazi Diana Ke · 2018 · Springer eBooks
  44. Protein–Protein Interactions in Neurodegenerative Diseases
    Krishna Mohan Poluri, Khushboo Gulati, Deepak Kumar Tripathi, Nupur Nagar · 2023 · Springer eBooks
  45. Pathophysiology and Management Approaches in Alzheimer’s Disease
    Shreshta Jain, Divya Goel, Sheikh Sana Nazir, Vaishali Yadav, Divya Vohora · 2023 · Springer eBooks
  46. Tau, Tangles and Tauopathies: Insights from Drosophila Disease Models
    Nisha Nisha, Pragati, Shweta Tandon, Aqsa Aqsa, Prerna Aggarwal, Surajit Sarkar · 2019 · Springer eBooks
  47. TSC1 loss-of-function increases risk for tauopathy by inducing tau acetylation and preventing autophagy-mediated tau clearance
    Carolina Alquézar, Kathleen M. Schoch, Ethan G. Geier, Eliana Marisa Ramos, Aurora Scrivo, Kathy K Li, Andrea R. Argouarch, Elisabeth E. Mlynarski, Beth A. Dombroski, Jennifer S. Yokoyama et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  48. Small-molecule ketone esters treat brain network abnormalities in an Alzheimer’s disease mouse model
    John C. Newman, Keran Ma, François Kroll, Erin Higgins, Scott Michael Ulrich, Jorge J. Palop, Eric M. Verdin · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  49. Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Mouse Models
    Janet van Eersel, Fabien Delerue, Lars Matthias Ittner, Yazi Diana Ke · 2014 · Springer eBooks
  50. Past, Present, and Future: The Behavioral Sciences.
    John G. Darley · 1971 · Contemporary Psychology
  51. Tackling TAUxicity
    Siân Lewis · 2015 · Nature reviews. Neuroscience
  52. Proteomics of neurodegenerative diseases using novel online isoelectric point separation
    Mohammad Pirmoradian · 2015 · Figshare
  53. Perspective, Summary, and Directions for Future Research on Alzheimer’s Disease
    A. A. Farooqui · 2017 · Elsevier eBooks
  54. Investigating the contribution of astrocytes and neuroinflammation to pathological tau changes in Alzheimer's disease
    Emma Claire Phillips · 2017 · Research Portal (King's College London)
  55. Review Article Tau: From research to clinical development
    David M. Holtzman, María C. Carrillo, James A. Hendrix, Lisa J. Bain, Ana María Catafau, Laura M. Gault, Michel Goedert, Eckhard Mandelkow�, Eva‐Maria Mandelkow, David S. Miller et al. · 2016
  56. Aktuelle Therapiestudien im Bereich der atypischen Parkinson Syndrome
    Kerstin Schweyer, Johannes Levin, Günter U. Höglinger · 2018 · Fortschritte der Neurologie · Psychiatrie
  57. Farnesyl Transferase Inhibition for the Treatment of Tauopathies
    Israel Hernández, Gabriel Luna, Jennifer N. Rauch, Michel Giroux, Celeste M M. Karch, Daniel Boctor, Nadia J Storm, Antonio Díaz, Cezary Żekanowski, Alexander A. Kang et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  58. Epigenetic Dysregulation in the Basocortical Cholinergic Projection System During the Progression of Alzheimer's Disease
    Laura J. Mahady · 2018
  59. Patent Highlights June–July 2016
    Hermann AM Mucke · 2016 · Pharmaceutical Patent Analyst
  60. The role of tau in Alzheimer’s Disease: Effects of Lys-280 and Lys-281 acetylation on tau function and structure
    Brian H. Constance · 2019 · Carolina Digital Repository (University of North Carolina at Chapel Hill)
  61. Pathological Tau as a Cause, and Consequence, of Cellular Dysfunction
    Shelby E. Meier · 2019 · UKnowledge (University of Kentucky)
  62. Effects of anle138b treatment on amyloid-β neurotoxicity
    Carolina Thomas · 2020
  63. THE ROLE OF MICROTUBULE-ASSOCIATED PROTEIN TAU IN NEURONAL EXCITABILITY AND EPILEPTOGENESIS
    Ryan Cloyd · 2021 · UKnowledge (University of Kentucky)
  64. The Role of Microglial-Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) in Neuronal Homeostasis and Tau Pathogenesis
    Vaishnavi Jadhav · 2021 · IUScholarWorks (Indiana University)
  65. Quantification and Analysis of Tau Protein Effects on Microtubule Dynamics in Mammalian (LLC-PK1) Cells
    Alexandra Doersch · 2020 · University of Minnesota Digital Conservancy (University of Minnesota)
  66. Cellular Mechanisms of Dementia
    Li Gan · 2017 · Oxford University Press eBooks
  67. Tau acetylation is an early pathological event in neurodegenerative disease
    2015 · Nature Reviews Neurology
  68. The proto-oncogene DEK regulates neuronal excitability and tau accumulation in Alzheimer’s disease vulnerable neurons
    Patricia Rodriguez‐Rodriguez, Luis Enrique Arroyo‐García, Lechuan Li, Christina Tsagkogianni, Wei Wang, Isabella Salas-Allende, Zakary Plautz, Ángel Cedazo-Mı́nguez, Subhash C. Sinha, Olga G. Troyanskaya et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Investigation of the role of prolyl isomerase A in protein misfolding associated with neurodegenerative diseases
    María Babu · 2023
  70. A Brief Review on Alzheimer’s Disease
    D Suvitha, P Dhivya, T Saraswathy, Ahamed Nisha K · 2023 · International Journal of Pharmacy and Pharmaceutical Research
  71. Sirtuins in the pathogenetic therapy of neurodegenerative diseases
    Ekaterina M. Samoilova, Alina A. Ivanova, Petr P. Laktionov, Кальсин Владимир Анатольевич, Stanislav E. Romanov · 2024 · Journal of clinical practice
  72. Post-translational modifications regulate conformational polymorphism of protein aggregates associated with neurodegenerative diseases
    Ruonan Wang, Zhongyi Jian, Lanlan Yu, Chenxuan Wang · 2024 · Scientia Sinica Chimica
  73. Molecular Signatures and Clinical Significance of Notch Signaling Pathway in Peripheral Blood of Patients with Alzheimer's Disease
    Dongdong Jia, Ting He, Lu Sun, Qi Wang, Haitao Yu · 2024 · Current Alzheimer Research
  74. Novel Approaches for Treating Alzheimer’s Disease and Other Dementias
    M. Catarina Silva, David C. Butler, Sally Temple, Stephen J. Haggarty · 2025
  75. Molecular and Cellular Mechanisms of Primary Tauopathies
    Shiaoching Gong, Li Gan · 2025
  76. Decoding the role of glucocorticoid-regulated kinase 1 in Alzheimer's disease: a promising path toward novel therapeutic strategies
    Yukti Mittal, Pankaj Kumar, Kajal Joshi, Khadga Raj Aran · 2025 · Inflammopharmacology
  77. Amyloid- and Tau-Targeted Therapies in Alzheimer’s Disease
    Alexander J. Rajic, Douglas R Galasko, Mark H. Tuszynski · 2025 · Springer eBooks
  78. Anti-inflammatory and immunomodulating agents
    Joy Lynne Britten · 2025 · Elsevier eBooks
  79. Additional file 5 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  80. Additional file 6 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Keith W. Nehrke · 2020 · Figshare
  81. Additional file 3 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  82. Additional file 2 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  83. Additional file 4 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Nehrke, Keith · 2020 · Figshare
  84. Additional file 1 of Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model
    Sanjib K Guha, Fischer, Sarah, Johnson, Gail V. W., Keith W. Nehrke · 2020 · Figshare
  85. Serotonergic psychedelics as epigenetic modulators: A paradigm shift in Alzheimer's disease therapeutics
    Esmaeel Ghasemi Gojani, Houman Farzin, Robert J. Sutherland, Majid H. Mohajerani · 2026 · Neuroscience & Biobehavioral Reviews
  86. Maladaptive aging trajectory in late-onset Alzheimer's disease
    Tao Lv, Huifang Sun, Tengyuan Xia, Man Lu Zhu, Yuhong Li · 2026 · The Innovation Life
  87. Unrevealing possible mechanism of Riluzole, Salsalate and Nimodipine in Alzheimer’s disease: multi-target network pharmacological perspective
    Kishor Kumar Roy, Dinesh Kumar Mehta, Rina Das · 2026 · Inflammopharmacology
  88. Biological Insights into Neurodegenerative Disorders and the Use of Drug Repurposing for Their Treatment
    Pratik Talukder, Rohan Banerjee, Soumoditya Banerjee · 2026 · BENTHAM SCIENCE PUBLISHERS eBooks
  89. Emerging Roles of Small-molecule Derivatives in Modulating Neurodegenerative Pathways: From Molecular Targets to Therapeutic Applications
    Kuldeep Singh, Pranshul Sethi, Divya Jain, Jeetendra Kumar Gupta, Omar Awad Alsaidan, Sami Ibrahim Alzarea, Arun H. S. Kumar, Mohammad Tabish, Mukesh Chandra Sharma · 2026 · Mini-Reviews in Medicinal Chemistry
  90. Drug Discovery for Alzheimer’s Disease: Current Status
    Michael S. Wolfe · 2026 · Topics in medicinal chemistry
  91. Rôle des modifications post-traductionnelles dans le processus d’agrégation de la protéine Tau
    Clément Despres · 2017
  92. Aspirin recapitulates features of caloric restriction
    Francesca Castoldi · 2018
  93. Neurotoxicité précoce et mécanismes de neuroprotection dans des modèles poisson‐zèbre de tauopathies
    Clément Barbereau · 2020 · theses.fr (ABES)
  94. Caractérisation d'anticorps à domaine unique dirigés contre la protéine Tau
    Clément Danis · 2018 · theses.fr (ABES)
  95. Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy
    Ania Goncalves · 2020 · theses.fr (ABES)
  96. Design, synthesis and characterization of protein-protein interaction disruptors related to early amyloidogenic phenomena in Alzheimer's disease
    Johanna Giovannini · 2021
  97. Liaison et impact du zinc sur deux protéines associées aux maladies neuro-dégénératives : tau et TDP-43
    Dahbia Yatoui · 2022
  98. Etude des mécanismes physiοpathοlοgiques de la maladie d'Alzheimer : appοrt de l'étude des variants du gène SΟRL1
    Romain Castelot · 2024 · theses.fr (ABES)
  99. Tau Aggregation Modulators
    Ibrar Ahmed Siddique, Megan Hong, Gal Bitan · 2026 · Topics in medicinal chemistry
  100. Concepts, types, and treatment strategies for neurodegenerative disorders
    Rafquat Rana, Srishty Jaiswal, Mitali Sethi, Shourya Tripathi, Keerti Mishra, Pallavi Gupta, Manish K. Chourasia · 2026 · Elsevier eBooks